Edwards Lifesciences Corporation
Simbolis: EW
NYSE
85.25
USDRinkos kaina šiandien
36.2756
P/E santykis
2.3277
PEG koeficientas
51.37B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Edwards Lifesciences Corporation (EW) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 6715.3 | 1644.5 | 1215.3 | 1466.8 | |||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1894 | 500.5 | 446.3 | 604 | |||||||||||||||||||||||||
balance-sheet.row.net-receivables | 3332.8 | 836.9 | 699.1 | 664.9 | |||||||||||||||||||||||||
balance-sheet.row.inventory | 4388.1 | 1168.2 | 875.5 | 726.7 | |||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 1081.2 | 239.3 | 195.9 | 237.1 | |||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 15920.7 | 4035.7 | 3095.8 | 3180.7 | |||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 7229 | 1843.4 | 1725.1 | 1638.7 | |||||||||||||||||||||||||
balance-sheet.row.goodwill | 5103.2 | 1253.5 | 1164.3 | 1167.9 | |||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1736.4 | 428.4 | 285.2 | 323.6 | |||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6839.6 | 1681.9 | 1449.5 | 1491.5 | |||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2600.3 | 583.9 | 1239 | 1834.2 | |||||||||||||||||||||||||
balance-sheet.row.tax-assets | 2793.9 | 754.6 | 484 | 246.7 | |||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 2090.8 | 463.7 | 299.1 | 110.8 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 21553.6 | 5327.5 | 5196.7 | 5321.9 | |||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-assets | 37474.3 | 9363.2 | 8292.5 | 8502.6 | |||||||||||||||||||||||||
balance-sheet.row.account-payables | 1671 | 201.4 | 201.9 | 204.5 | |||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 98.3 | 24.9 | 25.5 | 25.5 | |||||||||||||||||||||||||
balance-sheet.row.tax-payables | 440.9 | 122.3 | 96.2 | 99.5 | |||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 2594.2 | 670 | 665.8 | 664.8 | |||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 3448.7 | 15.2 | 311 | 3.9 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5692.6 | 1448.4 | 1463.4 | 1634.4 | |||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 357.2 | 97.9 | 95 | 94.6 | |||||||||||||||||||||||||
balance-sheet.row.total-liab | 10394.9 | 2643.8 | 2485.8 | 2666.7 | |||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.common-stock | 2601.3 | 650.5 | 646.3 | 642 | |||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 35196.8 | 8992.4 | 7590 | 6068.1 | |||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -981.7 | -242.8 | -254.9 | -157.7 | |||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -10015.3 | -2750.1 | -2174.7 | -716.5 | |||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 26801.1 | 6650 | 5806.7 | 5835.9 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 37474.3 | 9363.2 | 8292.5 | 8502.6 | |||||||||||||||||||||||||
balance-sheet.row.minority-interest | 278.3 | 69.4 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-equity | 27079.4 | 6719.4 | 5806.7 | 5835.9 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 37474.3 | - | - | - | |||||||||||||||||||||||||
Total Investments | 4494.3 | 1084.4 | 1685.3 | 2438.2 | |||||||||||||||||||||||||
balance-sheet.row.total-debt | 2769.7 | 694.9 | 691.3 | 690.3 | |||||||||||||||||||||||||
balance-sheet.row.net-debt | -2051.6 | -449.1 | -77.7 | -172.5 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1409.9 | 1399.4 | 1521.9 | 1503.1 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 148.2 | 144.9 | 139.6 | 134.8 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -256.1 | -272.1 | -254.5 | -41.4 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 145.1 | 139.4 | 126.8 | 109.3 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -928.7 | -526.3 | -421.4 | 145.3 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | -348.9 | -141.2 | -84.1 | -112.4 | |||||||||||||||||||||||||
cash-flows.row.inventory | -325.7 | -289 | -213.4 | 19 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 102.1 | 146 | -21.4 | 195.2 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | -378.1 | -242.1 | -102.5 | 43.5 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 9.8 | 10.5 | 105.8 | -119 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 528.2 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -290.1 | -266.3 | -264.8 | -329.8 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 149.2 | -95.2 | 0 | 329.8 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -88.2 | -105.5 | -778.9 | -1892.4 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 618.5 | 715.8 | 1359.1 | 529.2 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -153 | -75 | -63.1 | -359.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 236.4 | 173.8 | 252.3 | -1722.5 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -0.3 | -0.3 | -0.2 | -7 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 190.1 | 169.9 | 146.4 | 158.6 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -630.5 | -879.6 | -1727.1 | -512.8 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -169.9 | -146.4 | -158.6 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 30.9 | 168.9 | 142.8 | 163.5 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -442.7 | -711 | -1584.5 | -356.3 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 30.7 | 16.8 | 19.2 | 13.9 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 352.6 | 375.4 | -94.8 | -332.8 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4838.4 | 1148 | 772.6 | 867.4 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4485.8 | 772.6 | 867.4 | 1200.2 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 528.2 | 895.8 | 1218.2 | 1732.1 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -290.1 | -266.3 | -264.8 | -329.8 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 238.1 | 629.5 | 953.4 | 1402.3 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 6143.4 | 6004.8 | 5382.4 | 5232.5 | |||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 1434.5 | 1379.8 | 1080.4 | 1248.9 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit | 4708.9 | 4625 | 4302 | 3983.6 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.research-development | 1095.8 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0.4 | 3.4 | 2.6 | 12.7 | |||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 2974 | 2895.2 | 2512.8 | 2396.8 | |||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 4408.5 | 4275 | 3593.2 | 3645.7 | |||||||||||||||||||||||||
income-statement-row.row.interest-income | 30.5 | 67.2 | 35.5 | 17.4 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 27.8 | 17.6 | 19.2 | 18.4 | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -167 | -181.3 | 18.9 | 353.5 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.4 | 3.4 | 2.6 | 12.7 | |||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -167 | -181.3 | 18.9 | 353.5 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 27.8 | 17.6 | 19.2 | 18.4 | |||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 78 | 144.9 | 81.4 | 134.8 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1886.7 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.operating-income | 1583.4 | 1534.1 | 1748.5 | 1348.5 | |||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1608.9 | 1598.1 | 1767.4 | 1702 | |||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 199 | 198.7 | 245.5 | 198.9 | |||||||||||||||||||||||||
income-statement-row.row.net-income | 1413.8 | 1402.4 | 1521.9 | 1503.1 |
Dažnai užduodami klausimai
Kas yra Edwards Lifesciences Corporation (EW) bendras turtas?
Edwards Lifesciences Corporation (EW) bendras turtas yra 9363200000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 3132300000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.766.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.396.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.230.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.258.
Kas yra Edwards Lifesciences Corporation (EW) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 1402400000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 694900000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 2895200000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 1224600000.000.